Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10034 | 1034 | 41.1 | 82% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
168 | 21544 | ASYMMETRIC DIMETHYLARGININE//ENDOTHELIUM//ADMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PHYSIOL MORPHOL | Address | 70 | 60% | 7% | 77 |
2 | RAT AORTAE | Author keyword | 6 | 100% | 0% | 4 |
3 | CHARLIE NORWOOD VET ADM MED | Address | 3 | 60% | 0% | 3 |
4 | AORTIC REACTIVITY | Author keyword | 2 | 67% | 0% | 2 |
5 | TWO VEIN OCCLUSION | Author keyword | 2 | 67% | 0% | 2 |
6 | CARDIOVASC RECEPTOROL | Address | 1 | 50% | 0% | 2 |
7 | CHEMICALLY INDUCED DIABETES IN RATS | Author keyword | 1 | 100% | 0% | 2 |
8 | STREPTOZOTOCIN HYPERTENSIVE RATS | Author keyword | 1 | 100% | 0% | 2 |
9 | MESENTERIC RESISTANCE ARTERIES | Author keyword | 1 | 20% | 1% | 6 |
10 | MESENTERIC ARTERIAL BED | Author keyword | 1 | 15% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EDHF TYPE RELAXATION | 19 | 76% | 1% | 13 |
2 | CONTRACTILE RESPONSES | 13 | 16% | 7% | 75 |
3 | IMPAIRED CONTRACTION | 12 | 75% | 1% | 9 |
4 | ELEVATED GLUCOSE | 10 | 22% | 4% | 43 |
5 | TREATMENT INDUCED IMPROVEMENT | 5 | 63% | 0% | 5 |
6 | CHRONIC INSULIN | 4 | 75% | 0% | 3 |
7 | ENHANCED CONTRACTILE RESPONSES | 4 | 75% | 0% | 3 |
8 | MESENTERIC RESISTANCE ARTERIES | 4 | 16% | 2% | 24 |
9 | VASCULAR CONTRACTION | 3 | 33% | 1% | 7 |
10 | INTIMA MEDIA PREPARATION | 3 | 60% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Endothelial dysfunction in diabetes | 2000 | 630 | 102 | 52% |
Review of alterations in endothelial nitric oxide production in diabetes - Protective role of arginine on endothelial dysfunction | 1998 | 283 | 196 | 52% |
Endothelin-1 and diabetic complications: Focus on the vasculature | 2011 | 40 | 82 | 32% |
FREE-RADICALS IN DIABETIC ENDOTHELIAL-CELL DYSFUNCTION | 1994 | 291 | 72 | 29% |
ENDOTHELIUM-MEDIATED VASCULAR FUNCTION IN INSULIN-DEPENDENT DIABETES-MELLITUS | 1995 | 189 | 114 | 37% |
Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase | 2010 | 12 | 18 | 33% |
The diabetic vasculature: Physiological mechanisms of dysfunction and influence of aerobic exercise training in animal models | 2014 | 3 | 106 | 23% |
Possible involvement of insulin and oxidative stress in vascular dysfunction of diabetic mellitus | 2008 | 3 | 29 | 69% |
Reactive oxygen-derived free radicals are key to the endothelial dysfunction of diabetes | 2009 | 19 | 144 | 30% |
Protein kinase C in enhanced vascular tone in diabetes mellitus | 2014 | 5 | 198 | 13% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHYSIOL MORPHOL | 70 | 60% | 7.4% | 77 |
2 | CHARLIE NORWOOD VET ADM MED | 3 | 60% | 0.3% | 3 |
3 | CARDIOVASC RECEPTOROL | 1 | 50% | 0.2% | 2 |
4 | CARDIOVASC RISK TOR REDUCT UNIT | 1 | 15% | 0.6% | 6 |
5 | FROEDTERT MEM HOSP | 1 | 33% | 0.2% | 2 |
6 | AGING ANTIOXIDANT | 1 | 50% | 0.1% | 1 |
7 | ANIM BIOL PL BIOMED TECH | 1 | 50% | 0.1% | 1 |
8 | BIOMED SCI PHYSIOL GRP VASC BIOL | 1 | 50% | 0.1% | 1 |
9 | CENT HOSP MED ENDOCRINOL DIABET | 1 | 50% | 0.1% | 1 |
10 | CGT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000146615 | ENDOTHELIUM DEPENDENT CONTRACTIONS//ENDOTHELIUM DEPENDENT CONTRACTION//ENDOTHELIUM DERIVED CONTRACTING FACTOR |
2 | 0.0000138216 | NUTRITIVE FLOW//NON NUTRITIVE FLOW//INSULIN TRANSPORT |
3 | 0.0000112931 | GLICLAZIDE//INTERNAL MED DIABETOL CLIN PHARMACOL//DRUG QUAL CONTROL PHARMACOVIGILANC |
4 | 0.0000107869 | NA DEPENDENT CA2 UPTAKE//TISSUE INHIBITOR OF METALLOPROTEASE 2//PULMONARY ARTERY SMOOTH MUSCLE |
5 | 0.0000102354 | DIABETIC CARDIOMYOPATHY//DIABETIC HEART//ENVIRONM OCCUPAT AGR HLTH |
6 | 0.0000097969 | ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR//EDHF//ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR EDHF |
7 | 0.0000097659 | INTRAVITAL OBSERVATION//FLUORESCENCE VIDEOMICROSCOPY//IRIS MICROCIRCULATION |
8 | 0.0000090664 | DIABETOL DDG//JOHN COOK RENAL UNIT//PLATELET HYPERSENSITIVITY |
9 | 0.0000088226 | RUBOXISTAURIN//PENN MOL STUDIES KIDNEY DIS//BEETHAM EYE OPHTHALMOL |
10 | 0.0000086069 | UMR 6214//C3HEB FEJ//IFR CIRCULAT PARIS NORD |